Human T-lymphotropic virus (HTLV) is a human, single-stranded RNA retrovirus that causes T-cell leukemia and T-cell lymphoma in adults and may also be involved in certain demyelinating diseases.
HTLV was discovered in 1977 in Japan. It was later studied by Drs. Bernard Poiesz and Robert C. Gallo and their co-workers in the NCI; it was the first identified human retrovirus. Infection with HTLV-I, like infection with other retroviruses, probably occurs for life and can be inferred when antibody against HTLV-1 is detected in the serum. HTLV-I infection in the United States appears to be about half as prevalent as HIV infection among IV drug users and about one-tenth as prevalent in the population at large. Although little serologic data exist, prevalence of infection is thought to be highest among blacks living in the Southeast. A prevalence rate of 30% has been found among black intravenous drug abusers in New Jersey, and a rate of 49% has been found in a similar group in New Orleans. It is possible that prevalence of infection is increasing in this risk group.
Studies of HTLV-I antibody indicate that the virus is endemic in southern Japan, in the Caribbean, and in Africa.
Transmission of HTLV-I is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through blood transfusion or sharing of contaminated needles. The importance of the various routes of transmission is believed to vary geographically. In Japan, the geographic clustering of infection and the rarity of unprotected sexual contact suggest that the virus is more dependent on mother-to-child transmission. In the Caribbean, the geographic distribution of the virus is more uniform, and it is more common among those with many sexual partners, indicating that sexual transmission is more common.
The time between infection and onset of cancer also varies geographically. It is believed to be about sixty years in Japan, and less than forty years in the Caribbean.
The name HTLV-III was the former name of HIV in early AIDS literature, but has since fallen out of use.
Cantor et al., 1991. HTLV I/II seroprevalence and HIV/HTLV coinfection among United States intravenous drug users. J. Acquired Immune Defic-iency Syndrome. 4, 460-7.
Clark J. et al., 1985. Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica. Int. J. Cancer 36, 37-41.
Ewald, Paul W. Evolution of Infectious Disease. New York: Oxford UP, 1994.
Tajima, K. 1988. The T-and B-cell malignancy study group. The third nation-wide study on adult T-cell leukemia and lymphoma (ATL) in Japan: Characteristic patterns of HLA antigen and HTLV-1 infection in ATL patients and their relatives. Int. J. Cancer 41, 505-12.
HTLV | HTLV | ヒトTリンパ好性ウイルス | HTLV
This article is licensed under the GNU Free Documentation License.
It uses material from the
"Human T-lymphotropic virus".
Home Page • arts • business • computers • games • health • hospitals • home • kids & teens • news • physicians • recreation• reference • regional • science • shopping • society • sports • world